• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粒径、多分散性和聚合物降解对 PLGA 微球中孕酮释放的影响:实验和数学建模。

Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling.

机构信息

Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, Santa Fe, 3000, Argentina.

Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, Santa Fe, 3000, Argentina.

出版信息

Int J Pharm. 2018 Jan 30;536(1):360-369. doi: 10.1016/j.ijpharm.2017.12.006. Epub 2017 Dec 5.

DOI:10.1016/j.ijpharm.2017.12.006
PMID:29217474
Abstract

Poly(lactic-co-glycolic acid) (PLGA) microparticles containing progesterone were prepared by the solvent extraction/evaporation and microfluidic techniques. Microparticles were characterized by their size distribution, encapsulation efficiency, morphology and thermal properties. The effect of particle size, polydispersity and polymer degradation on the in vitro release of the hormone was studied. A triphasic release profile was observed for larger microparticles, while smaller microspheres showed a biphasic release profile. This behavior is related to the fact that complete drug release was achieved in a few days for smaller microparticles, during which polymer degradation effects are still negligible. A mathematical model was developed that predicts the progesterone release profiles from different-sized PLGA microspheres. The model takes into account both the dissolution and diffusion of the drug in the polymeric matrix as well as the autocatalytic effect of polymer degradation. The model was adjusted and validated with novel experimental data. Simulation results are in very good agreement with experimental results.

摘要

聚(乳酸-共-乙醇酸)(PLGA)载孕烯醇酮微球通过溶剂萃取/蒸发和微流控技术制备。微球的粒径分布、包封效率、形态和热性能进行了表征。研究了粒径、多分散性和聚合物降解对激素体外释放的影响。较大的微球表现出三相释放曲线,而较小的微球则表现出两相释放曲线。这种行为与以下事实有关:对于较小的微球,几天内即可实现药物的完全释放,在此期间,聚合物降解的影响仍然可以忽略不计。建立了一个数学模型,预测不同大小的 PLGA 微球中孕激素的释放曲线。该模型考虑了药物在聚合物基质中的溶解和扩散以及聚合物降解的自催化效应。使用新的实验数据对模型进行了调整和验证。模拟结果与实验结果非常吻合。

相似文献

1
Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling.粒径、多分散性和聚合物降解对 PLGA 微球中孕酮释放的影响:实验和数学建模。
Int J Pharm. 2018 Jan 30;536(1):360-369. doi: 10.1016/j.ijpharm.2017.12.006. Epub 2017 Dec 5.
2
Mathematical modeling of PLGA microparticles: from polymer degradation to drug release.聚乳酸-羟基乙酸共聚物微粒的数学建模:从聚合物降解到药物释放
Mol Pharm. 2014 Nov 3;11(11):4036-48. doi: 10.1021/mp500078u. Epub 2014 Oct 2.
3
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。
J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.
4
Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.采用流聚焦玻璃微流控器件制备用于药物输送的结构可生物降解聚合物微球。
ACS Appl Mater Interfaces. 2015 Oct 21;7(41):23132-43. doi: 10.1021/acsami.5b06943. Epub 2015 Oct 12.
5
How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.自催化如何加速基于聚乳酸-羟基乙酸共聚物(PLGA)的微粒的药物释放:定量研究。
Biomacromolecules. 2005 Jul-Aug;6(4):2312-9. doi: 10.1021/bm050228k.
6
Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.可生物降解的乳酸/乙醇酸聚合物的合成、表征、生物降解及药物递送应用:第三部分。药物递送应用。
Artif Cells Blood Substit Immobil Biotechnol. 2004;32(4):575-91. doi: 10.1081/bio-200039635.
7
Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.通过纳米晶体和水溶性聚合物模板技术提高灯盏花素在聚乳酸-羟基乙酸共聚物微粒中的包封率和生物利用度。
Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2.
8
A Mechanistic Model for Acidic Drug Release Using Microspheres Made of PLGA 50:50.一种使用50:50聚乳酸-羟基乙酸共聚物(PLGA)制成的微球实现酸性药物释放的机理模型。
Mol Pharm. 2016 Aug 1;13(8):2729-35. doi: 10.1021/acs.molpharmaceut.6b00313. Epub 2016 Jul 19.
9
The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.制剂变量对采用油中油单相溶剂蒸发法制备的载胰岛素聚(乳酸-乙醇酸共聚物)微球特性的影响。
Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003. Epub 2009 Aug 12.
10
Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.粒径对载吉非替尼聚乳酸-羟基乙酸共聚物微球药物负载及释放动力学的影响
Mol Pharm. 2017 Feb 6;14(2):459-467. doi: 10.1021/acs.molpharmaceut.6b00896. Epub 2016 Dec 27.

引用本文的文献

1
A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles.一个关于载药聚乳酸-羟基乙酸共聚物(PLGA)微粒的制剂参数和特性的数据集。
Sci Data. 2025 Mar 1;12(1):364. doi: 10.1038/s41597-025-04621-9.
2
Investigating How All-Trans Retinoic Acid Polycaprolactone (atRA-PCL) Microparticles Alter the Material Properties of 3D Printed Fibrin Constructs.研究全反式维甲酸聚己内酯(atRA-PCL)微粒如何改变3D打印纤维蛋白构建体的材料特性。
Macromol Biosci. 2025 May;25(5):e2400464. doi: 10.1002/mabi.202400464. Epub 2025 Jan 21.
3
In Vitro and Ex Vivo Evaluation of Novel Methacrylated Chitosan-PNIPAAm-Hyaluronic Acid Hydrogels Loaded with Progesterone for Applications in Vaginal Delivery.
负载孕酮的新型甲基丙烯酸化壳聚糖-聚N-异丙基丙烯酰胺-透明质酸水凝胶用于阴道给药的体外和离体评价
Polymers (Basel). 2024 Jul 30;16(15):2160. doi: 10.3390/polym16152160.
4
The Modified Exenatide Microspheres: PLGA-PEG-PLGA Gel and Zinc-Exenatide Complex Synergistically Reduce Burst Release and Shorten Platform Stage.改性艾塞那肽微球:PLGA-PEG-PLGA 凝胶和锌艾塞那肽复合物协同作用减少突释并缩短平台期。
AAPS PharmSciTech. 2023 Nov 30;24(8):251. doi: 10.1208/s12249-023-02705-6.
5
Preparation of Azoxystrobin-Zinc Metal-Organic Framework/Biomass Charcoal Composite Materials and Application in the Prevention and Control of Gray Mold in Tomato.制备嘧菌酯-锌基金属有机骨架/生物质炭复合材料及其在番茄灰霉病防治中的应用。
Int J Mol Sci. 2023 Oct 26;24(21):15609. doi: 10.3390/ijms242115609.
6
Fabrication of PEG-PLGA Microparticles with Tunable Sizes for Controlled Drug Release Application.用于药物控释应用的尺寸可调的聚乙二醇-聚乳酸-羟基乙酸共聚物微粒的制备
Molecules. 2023 Sep 18;28(18):6679. doi: 10.3390/molecules28186679.
7
Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression.蛋白水解抗性决定白蛋白纳米颗粒药物递送特性,并增加组织蛋白酶 B、D 和 G 的表达。
Int J Mol Sci. 2023 Jun 16;24(12):10245. doi: 10.3390/ijms241210245.
8
Sizing down and functionalizing polylactide (PLA) resin for synthesis of PLA-based polyurethanes for use in biomedical applications.为了合成用于生物医学应用的基于聚乳酸(PLA)的聚氨酯,对聚乳酸(PLA)树脂进行了缩合和功能化。
Sci Rep. 2023 Feb 9;13(1):2284. doi: 10.1038/s41598-023-29496-x.
9
Ketorolac-Loaded PLGA-/PLA-Based Microparticles Stabilized by Hyaluronic Acid: Effects of Formulation Composition and Emulsification Technique on Particle Characteristics and Drug Release Behaviors.透明质酸稳定的载酮咯酸的聚乳酸-羟基乙酸共聚物/聚乳酸基微粒:制剂组成和乳化技术对颗粒特性及药物释放行为的影响
Polymers (Basel). 2023 Jan 4;15(2):266. doi: 10.3390/polym15020266.
10
Direct Cardiac Epigenetic Reprogramming through Codelivery of 5'Azacytidine and miR-133a Nanoformulation.通过 5'氮杂胞苷和 miR-133a 纳米制剂的共递送实现心脏的直接表观遗传重编程。
Int J Mol Sci. 2022 Dec 2;23(23):15179. doi: 10.3390/ijms232315179.